Femtobiomed Inc. (XKON:327610)

South Korea flag South Korea · Delayed Price · Currency is KRW
585.00
-10.00 (-1.68%)
At close: Mar 30, 2026
Market Cap4.99B -88.7%
Revenue (ttm)389.96M -1.4%
Net Income-1.21B
EPS-876.00
Shares Out8.54M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume22
Average Volume25,113
Open595.00
Previous Close595.00
Day's Range585.00 - 595.00
52-Week Range360.00 - 6,200.00
Beta0.24
RSI32.27
Earnings Daten/a

About Femtobiomed

Femtobiomed Inc. engages in the development, manufacturing, and wholesale of medical devices and medical supplies in Korea. The company offers CELLSHOT, a versatile platform for small- to medium-scale cell processing; and CellShot suite that integrates hardware, consumables, protective buffers, and digital workflows into a single non-viral cell engineering platform. It also provides SmartDrop, an free-surface analysis platform. The company was founded in 2011 and is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 327610
Full Company Profile